The civic record
Read. Follow. Verify.Kansas HB 2526 Prohibits Step Therapy Requirements for Advanced Metastatic Cancer Drugs
Last action · April 10, 2026: Died in Committee
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Proposed
Health insurance plans in Kansas are prohibited from requiring patients with advanced metastatic cancer to try and fail on a different drug before covering an FDA-approved prescription medication prescribed for their condition.
Patients dealing with advanced metastatic cancer gain faster insurance access to prescribed treatments without having to try alternative therapies first, provided the drug is supported by peer-reviewed evidence and FDA approval.
- Step therapy, often called 'fail first,' is a protocol used by health insurers requiring patients to try cheaper or preferred medications before covering the drug originally prescribed by their healthcare provider. context
- House Bill 2526 was introduced in the 2025-2026 legislative session and ultimately died in committee. context
Who It Would Have Affected
Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.
health benefit plan enrollees
health insurance plans
Health insurance plans are prohibited from enforcing step therapy protocols for specific advanced metastatic cancer treatments.
healthcare practitioners
Practitioners treating advanced metastatic cancer patients can prescribe FDA-approved medications without prior step therapy mandates from insurers.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
What does this bill change for cancer patients in Kansas?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
This bill did not become law - Died in committee.
Procedural history
3 actions- Apr 10, 2026HouseDied in Committee
- Jan 23, 2026HouseIntroducedIntroduced
- Jan 23, 2026HouseCommitteeReferred to House Committee on Insurance
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Targeted Insurance Restriction
The bill creates a specific carve-out from standard step therapy rules exclusively for advanced metastatic cancer treatments.
Connected Entities
Sources
www.kslegislature.gov
Analysis Score
0–100- Significance20Lowered because this bill did not pass (its text scored 65)
- Controversy50Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz20Current news / social attention level
Publisher tools